MRI can help guide women's treatment decisions for DCIS
In women with ductal carcinoma in situ (DCIS), whether they chose local excisio...Read more on AuntMinnie.comRelated Reading:
Video from ISMRM 2022: Katja Pinker-Domenig on breast MRI
MRI double reading can reduce unnecessary biopsies
Breast MRI leads to more follow-up, healthcare costs
MRI, CEDM more accurate to measure post-therapy tumor response
Preoperative MRI benefits women with triple-negative breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 10, 2022 Category: Radiology Source Type: news
DCIS Recurrence Often Represents a New Primary Breast Cancer
(MedPage Today) -- NEW ORLEANS -- A search for biomarkers to predict recurrence of ductal carcinoma in situ (DCIS) instead showed that a substantial fraction of recurrences had genetically distinct features from the primary DCIS, questioning... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 11, 2022 Category: Hematology Source Type: news
Recurrent DCIS Can Be Genetically Distinct From Primary Lesion Recurrent DCIS Can Be Genetically Distinct From Primary Lesion
In more than 10% of cases, when ductal carcinoma in situ recurs in the same breast, the new lesion is genetically district from the original lesion.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Is Ductal Carcinoma in Situ Cancer Curable? Risks and Symptoms
Title: Is Ductal Carcinoma in Situ Cancer Curable? Risks and SymptomsCategory: Diseases and ConditionsCreated: 3/15/2022 12:00:00 AMLast Editorial Review: 3/15/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 15, 2022 Category: Cancer & Oncology Source Type: news
What Is the Survival Rate of Ductal Carcinoma in Situ? Stages
Title: What Is the Survival Rate of Ductal Carcinoma in Situ? StagesCategory: Diseases and ConditionsCreated: 3/15/2022 12:00:00 AMLast Editorial Review: 3/15/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 15, 2022 Category: Cancer & Oncology Source Type: news
Patients Confused, Concerned About Diagnosis, Treatment of DCIS
TUESDAY, Feb. 22, 2022 -- Patients with ductal carcinoma in situ (DCIS) report confusion and concern about diagnosis and treatment, according to a study published online Feb. 22 in Cancer.
Shoshana M. Rosenberg, Sc.D., M.P.H., from the Dana-Farber... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 22, 2022 Category: Pharmaceuticals Source Type: news
DCIS Diagnosis: Confusion Over Whether This Is Cancer or Not DCIS Diagnosis: Confusion Over Whether This Is Cancer or Not
Women diagnosed with ductal carcinoma in situ (DCIS) are often confused about the diagnosis and have lingering concerns about treatment, a new survey reveals.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 22, 2022 Category: Pathology Tags: Hematology-Oncology News Source Type: news
Magnetic tracing offers new option for assessing DCIS
Magnetic tracers have emerged as a way to map ductal carcinoma in situ (DCIS...Read more on AuntMinnie.comRelated Reading:
AI helps predict which DCIS patients need to be upstaged
Adding breast density to Tyrer-Cuzick influences risk assessment
High breast density, BMI interact to increase breast cancer risk
Should women over 75 continue to get breast screening?
Screening, socioeconomic status linked to breast cancer mortality (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 10, 2022 Category: Radiology Source Type: news
Changing Cancer Care, So Patients No Longer Feel Like a Number
“Having cancer is terrifying. It’s scary. And going to the hospital—I really felt like a number,” says Marc Hulett, who was diagnosed with prostate cancer in 2004.
Hulett had surgery to remove his prostate and has been on hormone therapy for 17 years. Every three months, he gets a blood test to monitor his progress, but he no longer feels like a number. He drives from his home in Palm Springs, Calif., to Los Angeles—which can take up to six hours—to see his oncologist, Dr. David Agus, at the Ellison Institute for Transformative Medicine.
As the name suggests, the Institute isn’t ju...
Source: TIME: Health - November 3, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthscienceclimate Source Type: news
Breast MRI during workup of DCIS can spur anxiety in women
Women undergoing breast MRI for evaluation of ductal carcinoma in situ experienc...Read more on AuntMinnie.comRelated Reading:
Contrast-enhanced mammography can predict underestimated DCIS
Prediction models can reduce false positives in breast MRI screening
DCIS shows as nonmass enhancement on breast MRI
Health practitioners overestimate likelihood of disease, study says
Women with DCIS have 3x the risk of breast cancer death (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 3, 2021 Category: Radiology Source Type: news
Bringing WISDOM to Breast Cancer Care
Dr. Laura Esserman answers the door of her bright yellow Victorian home in San Francisco’s Ashbury neighborhood with a phone at her ear. She’s wrapping up one of several meetings that day with her research team at University of California, San Francisco, where she heads the Carol Franc Buck Breast Care Center. She motions me in and reseats herself at a makeshift home office desk in her living room, sandwiched between a grand piano and set of enormous windows overlooking her front yard’s flower garden. It’s her remote base of operations when she’s not seeing patients or operating at the hospita...
Source: TIME: Health - October 22, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Source Type: news
DCIS shows as nonmass enhancement on breast MRI
Ductal carcinoma in situ (DCIS) diagnosed with conventional breast imaging usuall...Read more on AuntMinnie.comRelated Reading:
Contrast mammography plus ultrasound on par with MRI for preop staging
Out-of-pocket costs may block women from breast MRI
Researchers tout algorithm in classifying breast tissues
AI detects axillary lymph node metastasis on multiparametric MRI
Abbreviated breast MRI bests mammo, ultrasound for 2nd cancers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 6, 2021 Category: Radiology Source Type: news
DCIS: Biosignature Helps Guide Post-Lumpectomy Decisions DCIS: Biosignature Helps Guide Post-Lumpectomy Decisions
A new biosignature tool helps with treatment decisions after lumpectomy for ductal carcinoma in situ (DCIS), eg, by identifying those who can skip radiotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 17, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Surgical Technique May Cut Positive Margin Rates in DCIS
Cavity shave margin resections for pure ductal carcinoma in situ may lower risk for positive margins (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 21, 2021 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Journal, Source Type: news
Surgical Technique May Cut Positive Margin Rates in DCIS
WEDNESDAY, April 21, 2021 -- Cavity shave margin (CSM) resections may reduce positive margin rates in patients with pure ductal carcinoma in situ (DCIS), according to a study published in the April issue of the Journal of the American College of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 21, 2021 Category: Pharmaceuticals Source Type: news
